Retrospective analysis of all cases of operated CP in our institution. Results: From 1978 to 2012, 140 cases of operated CP could be reviewed (99 males (71%), Mean age=54 years (y) (ranging from 19 to 80y)). Mean time of symptoms among all patients was 19.5months (m), ranging from 8 days to 30y. An acute presentation (<3m of symptoms) was seen in 62 patients (44%), subacute (3-6m) in 23 patients (16.4%), and chronic (>6m) in 55 patients (39%). Table: Time of symptoms per etiology. The etiology of CP was Idiopatic in 76p (54%), post-Acute Idiopatic Pericarditis in 24p (17%), Tuberculous in 15p (11%), Purulent in 10p (7%), post-Cardiac surgery in 5p (3.6%), post-Radiotherapy in 3p (2%), uremia in 2p (1%). Figure 1 : Distribution of etiologies in relation with its chronology of symptoms. Conclusions: Post-Cardiac surgery and Radiotherapy are still an uncommon cause of CP. The vast majority of cases of chronic CP are idiopatic. The most acute presentation of CP is for patients with purulent CP (less than 1 months of symtoms), followed by uremic CP (1.4m) and Neoplasmic CP (1.7m). Congestive heart failure (124p, 87%), chest pain (46p, 33%) or fever (33, 23.4%). Forty-nine patients (35%) were in an advanced NYHA class (III or IV) before surgery. The most frequent etiology of CP was idiopatic (71%). In patients with a specific cause of CP, tuberculosis (11%) was the most frequent diagnosis. Sixteen patients (11%) died perioperatively. Predictors of perioperative mortality were age (66±11 vs 53±16 years, p=0.002), NYHA status III or IV (31% vs 62%, p=0.014) and presence of pericardial effusion (27% vs 60%, p=0.01). Overall mortality during FU (12 years (range 0.1 to 34.5y)) was 39%. Long-term FU analysis (124 patients) showed that independent predictors of death were age at surgery (HR 1.05, 95% CI: 1.017-1.088), a previous episode of acute pericarditis (HR 2.93, 95% CI 1.26-6.81) and a preoperative NYHA status III or IV (HR 4.03, 95% CI 1.79-9.05). Etiology did not have an impact neither in perioperative survival nor in the long-term FU. Among patients with arterial hypertension (AHT) those with drug resistance are still a challenge in treatment. Renal sympathetic denervation (RDN) offers a innovative treatment approach. However, intraoperative parameters able to predict the ablation success are still lacking. We sought to enlighten whether electric parameters assessed during the procedure help to establish a prognosis. Methods: 42 patients with AHT (mean RR 155/88mmHg; averaged age 58 years, 43% female) who underwent a RDN (Simplicity radiofrequency ablation catheter) were evaluated for the procedure derived mean of applied capacity, wall impedance and impedance decrease over time. After a follow up of 6 months the RDN success was defined as a drop off of the mean outpatients blood pressure by more than 10 mmHg. Results: After 6 months the mean BP drop off was -7/-3 mmHg. 26 patients (62%) responded to RDN (mean -16/-10 mmHg). Compared to them who failed to decrease with BP, those who respond had a similar number of ablation points per artery (responder 6,8 vs. non-responder 6,2). Responder showed neither a difference in averaged applied capacity (6,2 vs. 6,0 Watts) nor in their renal artery wall impedance at the begin of ablation (286 Ohm vs. 172 Ohm). But there was a trend to a faster impedance decrease within the first minute of two minutes (-16% vs. -11%; p=0,18) and a stronger relative fall of impedance compared to baseline impedance (-18% vs. -12%; p=0,09) in favour of patients who respond to RDN. Conclusion: Looking for RDN success predicting parameters the overall fall of artery wall impedance during ablation and especially its velocity within the first minute of the procedure are promising parameters to distinguish between responders and non-responders to that treatment. In contrast, the number of points burned as well as the power applied seem to be irrelevant to predict procedural success.
Conclusions: Idiopatic pericarditis is the most frequent cause of CP. Perioperative mortality is high. Factors associated with a poor perioperative outcome are age, advanced NYHA status and moderate or severe pericardial effusion. Longterm FU shows that independent predictors of poor outcome are age at surgery, advanced NYHA status and a previous episode of acute pericarditis. Among patients with arterial hypertension (AHT) those with drug resistance are still a challenge in treatment. Renal sympathetic denervation (RDN) offers a innovative treatment approach. However, intraoperative parameters able to predict the ablation success are still lacking. We sought to enlighten whether electric parameters assessed during the procedure help to establish a prognosis. Methods: 42 patients with AHT (mean RR 155/88mmHg; averaged age 58 years, 43% female) who underwent a RDN (Simplicity radiofrequency ablation catheter) were evaluated for the procedure derived mean of applied capacity, wall impedance and impedance decrease over time. After a follow up of 6 months the RDN success was defined as a drop off of the mean outpatients blood pressure by more than 10 mmHg. Results: After 6 months the mean BP drop off was -7/-3 mmHg. 26 patients (62%) responded to RDN (mean -16/-10 mmHg). Compared to them who failed to decrease with BP, those who respond had a similar number of ablation points per artery (responder 6,8 vs. non-responder 6,2). Responder showed neither a difference in averaged applied capacity (6,2 vs. 6,0 Watts) nor in their renal artery wall impedance at the begin of ablation (286 Ohm vs. 172 Ohm). But there was a trend to a faster impedance decrease within the first minute of two minutes (-16% vs. -11%; p=0,18) and a stronger relative fall of impedance compared to baseline impedance (-18% vs. -12%; p=0,09) in favour of patients who respond to RDN. Conclusion: Looking for RDN success predicting parameters the overall fall of artery wall impedance during ablation and especially its velocity within the first minute of the procedure are promising parameters to distinguish between responders and non-responders to that treatment. In contrast, the number of points burned as well as the power applied seem to be irrelevant to predict procedural success.
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Magnitude and time course of the sympathoinhibitory and blood pressure lowering effects of renal denervation in resistant hypertensive patients Introduction: In resistant hypertension renal denervation produces antihypertensive effects presumably mediated by a sympathetic deactivation. However few information is available on the time course of the sympathetic and blood pressure lowering effects of the procedure and their possible relationships. Methods: In 11 patients with resistant hypertension who underwent renal denervation we assessed clinic, beat-to-beat (Finapres) and ambulatory (Spacelabs) Blood Pressure (BP), Heart Rate (HR, EKG) and efferent sympathetic nerve traffic to skeletal muscle (MSNA, microneurography, peroneal nerve) at baseline 30, 90 and 180 days after the procedure. .8 mmHg; P<0.05). A similar trend was observed for ambulatory BP values, although the magnitude of the BP fall was consistently less (-7.6±2.4 mmHg for systolic and -8.6±3.1 mmHg for diastolic, P=0.06 and P<0.05, respectively). MSNA displayed a progressive reduction during the follow-up evaluation (30 days -6.2±3.8 bs/100hb, -9.1%; 90 days -12.8±3.0 bs/100hb, -18.9%; 180 days; -14.4±3.1 bs/100hb, -21.2%; P<0.01). HR was unaffected by the procedure, this being the case also for 24-hour ambulatory BP variability. No significant correlation was found between the clinic or ambulatory BP responses to renal denervation and the concomitant changes in MSNA and HR. Conclusions: Our data suggest that renal denervation exerts progressive sympathoinhibitory effects with an early onset during the follow-up. These effects, however, do not necessarily seem to be associated both temporally and quantitatively to the BP lowering responses to the procedure.
